bruising after semaglutide injection bruise Bruising: A Neglected, Though Patient-Relevant Complication of Insulin Injections Coming to Light from a Real-Life Nationwide Bruising After Semaglutide Injections: Causes

Recent studies have demonstrated new anti-inflammatory properties for GLP1-R agonists

Anything sold direct to consumers without a prescriber relationship should be treated as a red flag

This design enables three distinct pharmacological actions in a single molecule: GLP-1 receptor agonism : The two conjugated GLP-1 analog peptides activate GLP-1R to produce appetite suppression, glucose-dependent insulin secretion, glucagon suppression, and delayed gastric emptying GIP receptor antagonism : The antibody component blocks GIP signaling, which may reduce fat storage and modify energy metabolism Extended half-life : The antibody backbone provides a half-life of approximately 21 days -- three times longer than any approved weekly incretin therapy -- enabling once-monthly dosing The GIP antagonism approach is the most distinctive feature

PPAR, peroxisome proliferator-activated receptor gamma, PCSK9, proprotein convertase subtilisin/kexin type 9

Semaglutide Type : GLP-1 receptor agonist How it works : Mimics a hormone (GLP-1) that regulates appetite, insulin, and digestion

PlexusDx clinicians evaluate all medications you take, including corticosteroids, before starting or adjusting your GLP-1 therapy